Literature DB >> 16612637

Genotype-phenotype correlation and longitudinal course in ten families with Best vitelliform macular dystrophy.

B Wabbels1, M N Preising, U Kretschmann, A Demmler, B Lorenz.   

Abstract

AIM: Longitudinal course and genotype-phenotype correlation in patients and carriers with heterozygous mutations in hBEST1 (bestrophin).
METHODS: Thirteen patients and seven possible carriers were characterised by mutation analysis with SSCPA and direct sequencing, clinical examination and fundus autofluorescence (AF). Electrophysiology (EOG and mfERG) and optical coherence tomography (OCT) were additionally performed whenever possible.
RESULTS: We identified seven different heterozygous mutations in ten unrelated families with Best disease. I296del was the most frequent mutation. Five of nine individuals with I295del and two of three with N99K were asymptomatic carriers. One patient with I295del mutation had funduscopically unilateral Best disease. In three children (all with I295del), EOG initially showed a clearly present light peak that deteriorated during 5 years of follow-up in two of them. Increased AF corresponded well to funduscopically visible lesions. During 3-6 years of follow-up, the lesion area did not change significantly, but there were obvious changes in the inner structure of the lesion.
CONCLUSION: In the present series I295del, the most frequent mutation in our study, and N99K showed reduced penetrance. EOG was normal in young patients even if prime signs were visible. The lesion area did not depend on the mutation and did not correlate with VA. Lower VA was associated with a more irregular AF pattern due to scarring or haemorrhage. Our results indicate a disease causing effect that is cumulative over time.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16612637     DOI: 10.1007/s00417-006-0286-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  33 in total

1.  Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium.

Authors:  A D Marmorstein; L Y Marmorstein; M Rayborn; X Wang; J G Hollyfield; K Petrukhin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  Genetic counseling of families with Best macular dystrophy.

Authors:  L A Bard; H E Cross
Journal:  Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol       Date:  1975 Nov-Dec

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Standard for clinical electro-oculography. International Society for Clinical Electrophysiology of Vision.

Authors:  M F Marmor; E Zrenner
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

5.  Dark adaptation in patients with Best vitelliform macular dystrophy.

Authors:  W Baca; G A Fishman; K R Alexander; A M Glenn
Journal:  Br J Ophthalmol       Date:  1994-06       Impact factor: 4.638

6.  Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best's disease).

Authors:  A Marquardt; H Stöhr; L A Passmore; F Krämer; A Rivera; B H Weber
Journal:  Hum Mol Genet       Date:  1998-09       Impact factor: 6.150

7.  Vitelliform dystrophy: long-term observations on New Zealand pedigrees.

Authors:  R Clemett
Journal:  Aust N Z J Ophthalmol       Date:  1991-08

8.  A histopathologic study of Best's macular dystrophy.

Authors:  G T Frangieh; W R Green; S L Fine
Journal:  Arch Ophthalmol       Date:  1982-07

9.  Histopathology of Best's macular dystrophy.

Authors:  T A Weingeist; J L Kobrin; R C Watzke
Journal:  Arch Ophthalmol       Date:  1982-07

10.  Long-term evaluation of patients with Best's vitelliform dystrophy.

Authors:  C W Mohler; S L Fine
Journal:  Ophthalmology       Date:  1981-07       Impact factor: 12.079

View more
  27 in total

1.  Multimodal fundus imaging in Best vitelliform macular dystrophy.

Authors:  Daniela C Ferrara; Rogério A Costa; Stephen Tsang; Daniela Calucci; Rodrigo Jorge; K Bailey Freund
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04-23       Impact factor: 3.117

2.  Functional assessment of the fundus autofluorescence pattern in Best vitelliform macular dystrophy.

Authors:  Maurizio Battaglia Parodi; Pierluigi Iacono; Claudia Del Turco; Giacinto Triolo; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-10-21       Impact factor: 3.117

3.  Molecular consequences of BEST1 gene mutations in canine multifocal retinopathy predict functional implications for human bestrophinopathies.

Authors:  Karina E Guziewicz; Julianna Slavik; Sarah J P Lindauer; Gustavo D Aguirre; Barbara Zangerl
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-23       Impact factor: 4.799

4.  Imaging and the perspective of clinical electrophysiology.

Authors:  Ulrich Kellner
Journal:  Doc Ophthalmol       Date:  2007-12-19       Impact factor: 2.379

Review 5.  [Genetic diseases of the retinal pigment epithelium].

Authors:  M N Preising; B Lorenz
Journal:  Ophthalmologe       Date:  2009-04       Impact factor: 1.059

6.  Detailed analysis of retinal function and morphology in a patient with autosomal recessive bestrophinopathy (ARB).

Authors:  Christina Gerth; Robert J Zawadzki; John S Werner; Elise Héon
Journal:  Doc Ophthalmol       Date:  2008-11-05       Impact factor: 2.379

7.  Variable phenotypic expressivity in a Swiss family with autosomal dominant retinitis pigmentosa due to a T494M mutation in the PRPF3 gene.

Authors:  Veronika Vaclavik; Marie-Claire Gaillard; L Tiab; Daniel F Schorderet; Francis L Munier
Journal:  Mol Vis       Date:  2010-03-19       Impact factor: 2.367

8.  New VMD2 gene mutations identified in patients affected by Best vitelliform macular dystrophy.

Authors:  D Marchant; K Yu; K Bigot; O Roche; A Germain; D Bonneau; V Drouin-Garraud; D F Schorderet; F Munier; D Schmidt; P Le Neindre; C Marsac; M Menasche; J L Dufier; R Fischmeister; C Hartzell; M Abitbol
Journal:  J Med Genet       Date:  2007-02-07       Impact factor: 6.318

Review 9.  Functional roles of bestrophins in ocular epithelia.

Authors:  Alan D Marmorstein; Harold E Cross; Neal S Peachey
Journal:  Prog Retin Eye Res       Date:  2009-05-04       Impact factor: 21.198

10.  Functional and clinical data of Best vitelliform macular dystrophy patients with mutations in the BEST1 gene.

Authors:  Giuseppe Querques; Jennyfer Zerbib; Rossana Santacroce; Maurizio Margaglione; Nathalie Delphin; Jean-Michel Rozet; Josseline Kaplan; Domenico Martinelli; Nicola Delle Noci; Gisèle Soubrane; Eric H Souied
Journal:  Mol Vis       Date:  2009-12-31       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.